Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
The Journal of Nutrition|February 24, 2012
High-fat and fructose intake induces insulin resistance, dyslipidemia, and liver steatosis and alters in vivo macrophage-to-feces reverse cholesterol transport in hamstersFrançois Briand, Quentin Thiéblemont, Elodie Muzotte, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|November 10, 2012
Upregulating reverse cholesterol transport with cholesteryl ester transfer protein inhibition requires combination with the LDL-lowering drug berberine in dyslipidemic hamstersFrançois Briand, Quentin Thieblemont, Elodie Muzotte, et al.Clinical and Translational Science|January 4, 2012
CETP inhibitor torcetrapib promotes reverse cholesterol transport in obese insulin-resistant CETP-ApoB100 transgenic miceFrançois Briand, Quentin Thieblemont, Agnès André, et al.European Journal of Pharmacology|November 21, 2017
Obeticholic acid raises LDL-cholesterol and reduces HDL-cholesterol in the Diet-Induced NASH (DIN) hamster modelFrançois Briand, Emmanuel Brousseau, Marjolaine Quinsat, et al.The Journal of Pharmacology and Experimental Therapeutics|September 3, 2020
Ezetimibe Enhances Macrophage-to-Feces Reverse Cholesterol Transport in Golden Syrian Hamsters Fed a High-Cholesterol DietFatima Kasbi Chadli, Morgan Treguier, François Briand, et al.Dose-Response : a Publication of International Hormesis Society|May 23, 2022
Highly Diluted Antibodies to eNOS Restore Endothelium Function in Aortic Rings From Hypertensive RatsNataliya V Petrova, Sergey A Tarasov, Oleg I Epstein, et al.Journal of Lipid Research|December 8, 2009
Liver X receptor activation promotes macrophage-to-feces reverse cholesterol transport in a dyslipidemic hamster modelFrançois Briand, Morgan Tréguier, Agnès André, et al.Atherosclerosis|February 18, 2014
Raising HDL with CETP inhibitor torcetrapib improves glucose homeostasis in dyslipidemic and insulin resistant hamstersFrançois Briand, Bénédicte Prunet-Marcassus, Quentin Thieblemont, et al.Obesity (Silver Spring, Md.)|February 25, 2026
Retatrutide Shows Multiple Metabolic Benefits in Diet-Induced Obese MASH Mouse and Hamster ModelsFrançois Briand, Camille Le Cudennec, Estelle Grasset, et al.European Journal of Pharmacology|July 11, 2014
Anacetrapib and dalcetrapib differentially alters HDL metabolism and macrophage-to-feces reverse cholesterol transport at similar levels of CETP inhibition in hamstersFrançois Briand, Quentin Thieblemont, Elodie Muzotte, et al.Pageof 5